Stay updated on Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T12:59:42.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T13:19:39.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The study record page now returns a 403 Forbidden page, replacing the previous content with a standard error page and site footer. This alters how users access the study details, effectively blocking view of the trial information.
    Difference
    19%
    Check dated 2026-09-19T18:20:16.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page shows a new revision number, updated from v3.6.5 to v3.6.6. This indicates a routine maintenance update that does not change the study information presented on the page.
    Difference
    0.1%
    Check dated 2026-08-29T20:56:14.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was applied, updating the page's version indicator from v3.6.4. It appears to be a minor internal update rather than a substantive modification to the study information.
    Difference
    0.1%
    Check dated 2026-08-08T23:43:40.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.4, replacing the previous v3.6.3. This indicates a minor update to the page content or its metadata.
    Difference
    0.1%
    Check dated 2026-07-25T16:47:05.000Z thumbnail image

Stay in the know with updates to Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page.